Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The accumulation of amyloid-β (Aβ) peptides in the brain of patients with Alzheimer's disease (AD) may arise from an imbalance between Aβ production and clearance. Overexpression of the Aβ-degrading enzyme neprilysin in brains of human amyloid precursor protein (hAPP) transgenic mice decreases overall Aβ levels and amyloid plaque burdens. Because AD-related synaptic and cognitive deficits appear to be more closely related to Aβ oligomers than to plaques, it is important to determine whether increased neprilysin activity also diminishes the levels of pathogenic Aβ oligomers and related neuronal deficits in vivo. To address this question, we crossed hAPP transgenic mice with neprilysin transgenic mice and analyzed their offspring. Neprilysin overexpression reduced soluble Aβ levels by 50% and effectively prevented early Aβ deposition in the neocortex and hippocampus. However, it did not reduce levels of Aβ trimers and Aβ*56 or improve deficits in spatial learning and memory. The differential effect of neprilysin on plaques and oligomers suggests that neprilysin-dependent degradation of Aβ affects plaques more than oligomers and that these structures may form through distinct assembly mechanisms. Neprilysin's inability to prevent learning and memory deficits in hAPP mice may be related to its inability to reduce pathogenic Aβ oligomers. Reduction of Aβ oligomers will likely be required for anti-Aβ treatments to improve cognitive functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like other hAPP Tg mice, hAPP J20 mice show deficits in spatial and nonspatial learning and memory (Cheng et al., 2007;Meilandt et al., 2009;Harris et al., 2010;Cisse ´et al., 2011).”
From Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease (2017) · cites this paper as Meilandt et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 12×
“NEP overexpression does not reduce pathogenic A oligomers in hAPP mice Why does a 50% reduction of overall A levels fail to improve cognitive function and neuronal Fos expression in hAPP-J20/ NEP mice? To address this question, we measured A *56, a pathogenic A oligomer that correlates closely with learning and memory…”
BackgroundMethodResultInfluentialRetractedShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 8×
“…phenotype in this paradigm, avoiding the open arms less than NTG controls (Chin et al., 2005b; Kobayashi and Chen, 2005; Cheng et al., 2007; Roberson et al., 2007). hAPP-J20 and hAPP-J20/NEP mice showed comparable abnormalities in this paradigm, with both groups traveling a greater…”
BackgroundMethodInfluentialSelf-citationMucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 12×
“Mice used in this study included nontransgenic (NTG) and heterozygous transgenic (TG) mice from hAPP lines J9 and J20, which express hAPP with the Swedish (K670N, M671L) and Indiana (V717F) FAD mutations (hAPPFAD) directed by the platelet-derived growth factor chain promoter (Rockenstein et al., 1995; Mucke et al., 20…”
BackgroundMethodInfluentialSelf-citationPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 5×
“NEP overexpression prevents hyperactivity but not alterations in anxiety/exploration-related behavior in hAPP mice In addition to deficits in learning and memory, hAPP mice and humans with AD have alterations in a variety of other behavioral domains (Kobayashi and Chen, 2005; Palop et al., 2006; Cheng et al., 2007; Fa…”
BackgroundInfluentialSelf-citationShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · cited 2×
“Because A -induced neuronal deficits appear to be mediated by A oligomers (Gong et al., 2003; Lacor et al., 2004; Lesné et al., 2006; Townsend et al., 2006; Cheng et al., 2007; Walsh and Selkoe, 2007), we wondered whether increased NEP expression can reduce A oligomer levels in vivo and prevent…”
BackgroundSynaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Research works printed but not linked: 54
- 10.1159/000112509 · DOI · Paper page
- 10.1002/cne.20117 · DOI
- 10.1074/jbc.M701078200 · DOI · Paper page
- 10.1042/0264-6021:3510509 · doi:10.1042/0264-6021:3510509 · Paper page
- Chin, 2005, Increasing Fyn kinase activity in APP transgenic mice impairs Arc expression induced by novel environment exposure, Soc Neurosci Abstr, 31, 324
- 10.1523/JNEUROSCI.2980-05.2005 · DOI · Paper page
- 10.1073/pnas.0509725103 · DOI
- 10.1074/jbc.M800247200 · DOI
- 10.1016/j.neurobiolaging.2006.10.021 · DOI
- 10.1016/j.amjmed.2006.08.036 · DOI · Paper page
- 10.2353/ajpath.2007.070105 · DOI
- 10.1016/S0140-6736(05)67889-0 · DOI · Paper page
- 10.1016/j.neuron.2008.03.015 · DOI · Paper page
- 10.1074/jbc.M401891200 · DOI · Paper page
- 10.1016/j.neurobiolaging.2006.10.010 · DOI · Paper page
- 10.1016/0896-6273(95)90107-8 · DOI · Paper page
- 10.1074/jbc.M601372200 · DOI · Paper page
- 10.1371/journal.pone.0001703 · DOI · Paper page
- 10.1126/science.1059946 · DOI · Paper page
- 10.1002/jnr.10390 · DOI · Paper page
- 10.1523/JNEUROSCI.4792-03.2004 · DOI · Paper page
- 10.1016/j.pharmthera.2005.03.010 · DOI · Paper page
- 10.1016/S0304-3940(03)00898-X · DOI · Paper page
- 10.1523/JNEUROSCI.5543-03.2004 · DOI · Paper page
- 10.1111/j.1601-183X.2005.00124.x · DOI · Paper page
- 10.1016/S0896-6273(03)00787-6 · DOI · Paper page
- 10.1111/j.1528-1167.2005.00406.x · DOI
- Manson, 1992, The prion protein gene: a role in mouse embryogenesis?, Development, 115, 117, 10.1242/dev.115.1.117 · DOI · Paper page
- 10.1023/A:1023211323853 · DOI
- Marr, 2003, Neprilysin gene transfer reduces human amyloid pathology in transgenic mice, J Neurosci, 23, 1992, 10.1523/JNEUROSCI.23-06-01992.2003 · DOI · Paper page
- 10.1016/S0960-9822(06)00287-9 · DOI · Paper page
- 10.1038/nm1423 · DOI · Paper page
- 10.1523/JNEUROSCI.0590-08.2008 · DOI
- 10.1016/S0306-4522(98)00599-5 · DOI
- 10.1074/jbc.274.10.6483 · DOI · Paper page
- 10.1016/j.bbr.2005.10.014 · DOI
- 10.1016/j.neuron.2006.07.027 · DOI · Paper page
- 10.1016/j.bbr.2004.05.028 · DOI
- 10.1038/nature05289 · DOI · Paper page
- 10.1016/j.nbd.2006.08.003 · DOI · Paper page
- 10.1126/science.1132813 · DOI · Paper page
- 10.1074/jbc.M507016200 · DOI · Paper page
- 10.1074/jbc.270.47.28257 · DOI · Paper page
- 10.1016/0196-9781(90)90084-I · doi:10.1016/0196-9781(90)90084-i
- 10.1016/S0896-6273(01)00475-5 · DOI · Paper page
- 10.1074/jbc.M008511200 · DOI · Paper page
- 10.1002/(SICI)1097-4547(19990901)57:5<651::AID-JNR7>3.0.CO;2-G · DOI
- 10.1159/000113690 · DOI
- 10.1113/jphysiol.2005.103754 · DOI · Paper page
- Tucker, 2000, The plasmin system is induced by and degrades amyloid-beta aggregates, J Neurosci, 20, 3937, 10.1523/JNEUROSCI.20-11-03937.2000 · DOI · Paper page
- 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K · DOI · Paper page
- 10.1038/341546a0 · DOI · Paper page
- 10.1021/bi001048s · DOI · Paper page
- 10.1046/j.0953-816x.2001.01803.x · DOI · Paper page
Cited by
Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009979 · Cited by 1,033
“In addition, the reduction in Ab42 did not likely arise from increased degradation, since levels of the two major Ab-degrading activities, neprilysin (NEP)[35], and insulin-degrading enzyme (IDE)[38] were unchanged in brains of control- and rapamycin-fed PDAPP mice as well (Fig.”
BackgroundMethodResultNetwork abnormalities and interneuron dysfunction in Alzheimer disease
Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022
Self-citationStem cells in human neurodegenerative disorders — time for clinical translation?
Lindvall, O., & Kokaia, Z. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40543 · Cited by 614
Mainardi, M., Di Garbo, A., Caleo, M., Berardi, N., Sale, A., & Maffei, L. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00001 · Cited by 545
Alzheimer's disease: synaptic dysfunction and Aβ
Shankar, G. M., & Walsh, D. M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-48 · Cited by 486
Metadata
- Authors
- Meilandt, W. J., Cisse, M., Ho, K., Wu, T., Esposito, L. A., Scearce-Levie, K., Cheng, I. H., Yu, G.-Q., & Mucke, L.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-02-18
- Volume
- 29
- Issue
- 7
- Pages
- 1977-1986
- ISSN
- 0270-6474
- 1529-2401
- Cited by
- 126
- References
- 14
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice. https://app.cochat.ai/papers/10.1523/jneurosci.2984-08.2009
- The paper
- Meilandt, W. J., Cisse, M., Ho, K., Wu, T., Esposito, L. A., Scearce-Levie, K., Cheng, I. H., Yu, G.-Q., & Mucke, L. (2009). Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.2984-08.2009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.